Kennedy Capital Management’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$220K	Sell	9,508 -7,093	-43%	-$164K	0.01%	564
2025 Q1	$448K	Buy	16,601 +3,888	+31%	+$105K	0.01%	588
2024 Q4	$681K	Buy	12,713 +928	+8%	+$49.7K	0.02%	623
2024 Q3	$535K	Buy	11,785 +1,805	+18%	+$82K	0.01%	633
2024 Q2	$418K	Buy	+9,980	New	+$418K	0.01%	647